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Protective Effects of Selol Against Sodium Nitroprusside-Induced 
Cell Death and Oxidative Stress in PC12 Cells
Agnieszka Dominiak1 · Anna Wilkaniec2 · Piotr Wroczyński1 · Henryk Jęśko2 · 
Agata Adamczyk2
suggest that Selol effectively protected PC12 cells against 
SNP-induced oxidative damage and death by adjusting 
free radical levels and antioxidant system, and suppressing 
apoptosis. Selol could be successfully used in the treat-
ments of diseases that involve oxidative stress and result-
ing apoptosis.
Keywords Antioxidative defense · Cytoprotection · 
Oxidative/nitrosative stress · Org n c selenium 
compound · Selenoenzymes · Selol
Introduction
Selenium (Se) is an essential trace element that is biologi-
cally active in the form of Se-containing selenoproteins. 
This mineral when replaced the sulfur atom in the amino 
acid cysteine (Cys) forms selenocysteine (Sec), which is the 
21st proteinogenic amino acid. Selenium appears to have a 
multifaceted role in the homoeostasis of central nervous sys-
tem (CNS) including the maintenance of cellular redox sta-
tus, mitochondrial dynamics, regulation of Ca2+ channels, 
and modulation of neurogenesis. Oxidative stress is defined 
as an imbalance between the generation and detoxification 
of reactive oxygen species (ROS). Brain is particularly vul-
nerable to oxidative stress due to its high oxygen demand (it 
takes up to 20 % of the total oxygen consumed), high lev-
els of iron and unsaturated fatty acids along with relatively 
inefficient antioxidative defense [1]. Oxidative stress plays 
an important role in brain aging as well as in various neu-
rodegenerative diseases [2 , 3] along with the deregulation 
of nitric oxide (NO)-based signaling, neurotransmission, 
and immune function [4]. The association between the risk 
of neurodegenerative diseases and the antioxidative capac-
ity has been demonstrated by numerous studies, suggesting 
Abstract Selol is an organic selenitetriglyc ride ormu-
lation containing selenium at +4 oxidation level that can 
be effectively incorporated into catalytic ites of of Se-
dependent antioxidants. In the present study, the potential 
antioxidative and cytoprotective effect  of Selol against 
sodium nitroprusside (SNP)-evoked oxidative/nitrosative 
stress were investigated in PC12 cells and the underlying 
mechanisms analyzed. Spectrophoto- and spectrofluori-
metic methods as well as fluorescence microscopy were 
used in this study; mRNA expression was quantified by 
real-time PCR. Selol dose-dependently improved the sur-
vival and decreased the percentage of apoptosis in PC12 
cells exposed to SNP. To determine the mechanism of 
this protective action, the effect of Selol on free radical 
generation and on antioxidative potent al was evalu ted. 
Selol offered significant protection against the elevation of 
reactive oxidative species (ROS) evoked by SNP. More-
over, this compound restored gluta h one home stasis by 
ameliorating the SNP-evoked disturbance of GSH/GSSG 
ratio. The protective effect exerted by Selol was ass ciated 
with the prevention of SNP-mediated down-regulation of 
antioxidative enzymes: glu athione peroxidase (Se-GPx), 
glutathione reductase (GR), and thior dox n r ductase 
(TrxR). Finally, GPx inhibition significantly abolished the 
cytoprotective effect of Selol. In conclusion, thes  results 
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not revealed any mutagenic potential up to 5000 Se µg/plate 
in Salmonella typhimurium/microsome mutagenicity assay 
[31, 32 ]. The compound undergoes rapid resorption from 
the digestive system and it is widely distributed in the organ-
ism. In particular, this lipophilic compound has the ability to 
cross the blood–brain barrier. Furthermore, it is completely 
eliminated from the organism after 24 h from dministra-
tion, avoiding accumulation and toxic effects [33]. While 
the efficiency of other organic selenium compounds against 
oxidative stress has been highlighted, it remains unknown 
whether Selol can antagonize SNP-induced damage.
The aim of the present study was to investigate the poten-
tial antioxidative and cytoprotective effects of Selol against 
SNP-evoked oxidative/nitrosative stress in rat pheochromo-
cytoma (PC12) dopaminergic cells and to explain the under-
lying mechanism of these effects.
Materials and Methods
Compounds and Reagents
Selol was synthesized at the Department of Bioanalysis and 
Drug Analysis at Medical University of Warsaw (Polish Pat-
ent 1999). A micellar solution of Selol was prepared ex tem-
pore (based on lecithin, water, and Selol), with a declared 
selenium concentration of 5 % (w/v).
Dulbecco’s modified Eagle’s medium (DMEM), fetal 
bovine serum (FBS), horse serum (HS), penicillin, streptomy-
cin, l-glutamine, 3-(4,5-dimethyl-2-tiazolilo)-2,5-diphenyl-2 
H-tetrazolium bromide (MTT), 2′-(4-hydroxyphenyl)-5-
-(4-methyl-1-piperazinyl)-2,5′-bi-1H-benzimidazoletrihy
drochloridehydrate (Hoechst 33258), TRI-reagent, poly-
ethylenoimine (PEI), dimethyl sulfoxide (DMSO), sodium 
aurothiomalate (SAu), sodium selenite (Na2SeO3), reduced 
glutathione (GSH), glutathione reductase (GR), the reduced 
form of nicotinamide adenine dinucleotide phosphate 
(NADPH), sodium azide, tert-butylperoxide, 2-vinylpyri-
dine, triethanolamine, metaphosphoric acid, bovine serum 
albumin (BSA), and all other common reagents were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Reagents for reverse transcription (High Capacity RNA-
to-cDNA Master Mix) and PCR (Gene Expression Master 
Mix) were from Applied Biosystems (Applied Biosystems, 
Foster City, CA, USA).
Cell Culture
The studies were carried out using rat pheochromocytoma 
cells (PC12) that were a kind gift from Prof. A. Eckert (Uni-
versity of Basel, Basel, Switzerland). All cell lines were 
cultured in DMEM supplemented with 10 % heat-inacti-
vated FBS and 5 % heat-inactivated HS, 50 U/ml penicillin/
the importance of antioxidants as disease-preventing g nts 
[5–7]. Free radical-dependent macromolecular da age 
is involved in the pathogenesis of Alzheimer’s (AD) and 
Parkinson’s (PD) diseases, multiple sclerosis (MS), amyo-
trophic lateral sclerosis (ALS), a d other age-related neu-
rodegenerative disorders [4, 8–12]. Various experimental 
tools have been developed to st mulate oxidative/nitrosativ  
stress in biological mater al. Sodi m ni roprusside (SNP) 
releases NO, but can also elevate cellular levels of Fe2+, 
H 2O 2 , and [Fe(CN6)]
4− [13]. Direct antioxidant role of Se 
in the CNS seems to be well establish d. Se is an integral 
constituent of antioxidant enzymes, suc  as glutathione per-
oxidases (GPxs) and thioredox n reductases (TrxRs). Other 
selenoproteins cleave iodine–carbon bonds in the metabo-
lism of thyroid hormones (iodothyronine deiodinase; DIOs) 
and are involved in the regulation of Ca2+ i flux (sel nopro-
tein M). Yet others catalyze the reduction of protein-based 
methionine-R-sulfoxide to methionine (selenoprotein R) or 
chelate heavy metals (selenoprotein P) [14–16]. Accumula-
tion of free radicals and generation of excessive ROS in aged 
brain are accompanied with lower Se levels, which might 
significantly contribute to neuropsychological decline [17]. 
Se deficit is further escalated (along ROS accumulation) in 
neurodegenerative disorders, particularly in the brain  of
AD patients [18–22 ]. Se concentration ends to d crease 
also in the serum of patients with MS [23 ] and in autop y 
brains from patients with Huntington’s disease [24].
The association of oxidative stress nd selenium dis-
turbances with neurodegenerative disorders suggests that 
Se administration might be usef l in their prevention and 
treatment. However, the currently available evide ce on the 
precise effects of different forms a d doses of Se is incon-
clusive. Therefore, there is stil  a ne d for novel, more effec-
tive compounds. Efficient uptake and metabolism of dietary 
Se strongly depend on its chemical form. Water-soluble s l-
enite and selenate are commonly used inorganic forms of Se 
[25 ]. However, the results of Letavayová et al. suggest that
inorganic Se donors might be more toxic an  have lower 
intestinal absorption efficacy than organic Se species [26]. 
Organic Se sources mostly include the following amino 
acids: SeMet (sl nomethionine), Sec (selenocysteine), 
and MeSeCys (methylselenocysteine) [27 ]. Other organic 
Se compounds include selenoneine, Se-enrich d yeast, and 
synthetic ethaselen or ebselen [28 , 29].
Drawing from the currently available data, we set out 
to investigate the organic Se-containing compound, Selol, 
which was first synthesized at Warsaw Medical University, 
Poland (Polish Patent 1999) [30]. Selol is a semi-synthetic 
mixture of organic selenitetriglycerid s obtain  from sun-
flower oil, containing Se at the +4 oxidation l vel. Pr vi-
ous results indicated that Selol did not exhibit any toxic 
potential after parenteral adm nistration at concentrations of 
500 mg/kg s.c and 100 mg/kg i.p and below, and also it has 
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to determine protein concentration. Se-glutathione peroxi-
dase (Se-GPx) activity was measured indirectly with tert-
butyl hydroperoxide (t-Bu-OOH) as a substrate in a reaction 
that progresses proportionally to the rate of NADPH oxi-
dation by GR. The reaction mixture contained optimized 
concentrations of the following chemicals in final volume 
220 µl: reduced glutathione (1.0 mM), NADPH (65 µM), 
and sodium azide (0.17mM). Th  reaction was started by 
adding t-butyl hydroperoxide (0.02 mM) and carried out at 
25  °C. The decrease in absorbance (proportional to Se-GPx 
activity) was measured once every 5 min at 340 nm. Th
results were expressed as U/mg protein.
Determination of Glutathione Reductase Activity
After 24 h of treatment with the tested compounds, GR 
activity was measured using spectrophotometric GR Assay 
Kit (Item No. 703202, Cayman Chemical, Ann Arbor, 
USA). Cells were homogenized in cold buffer (50 mM 
potassium phosphate, pH 7.5, containing 1 mM EDTA) 
and centrifuged (10,000×g, 15 min, 4 °C), and the result-
ing supernatant (20 µl) was used to analyze enzyme activity 
and to determine protein concentration. GR catalyzes the 
reduction of oxidized glutathione (GSSG) to GSH with a 
consumption of one NADPH. Briefly, the reaction mixture 
contained 50 mM potassium phosphate (pH 7.5), 1 mM 
EDTA and 1 mM GSSG. The reaction was initiated by add-
ing 50 µl NADPH and the decrease in absorbance caused 
by the oxidation of NADPH to NADP+ was measured once 
every 5 min at 340 nm. The results were presented as nmol/
min/mg of protein.
Determination of Glutathione Levels
After 24 h of treatment with the tested compounds, total 
(i.e., both oxidized and reduced) and oxidized glutathione 
(GSSG) levels were measured using enzymatic Glutathione 
Assay Kit (Item No. 703002, Cayman Chemical, Ann Arbor, 
USA). Cells were homogenized in cold buffer (50 mM 
MES, pH 6–7, containing 1 mM EDTA) and centrifuged 
(10,000×g, 15 min, 4 °C). The supernatant was used to deter-
mine protein content and is deproteinated before analysis. 
GSSG concentration was determined by derivatization tech-
nique. The reaction was initiated by adding freshly prepared 
assay cocktail and the change in absorbance was detected 
at 405 nm after 25 min. GSH was quantified using the fol-
lowing equation: GSH Total glutathione GSSG= − ×2 . The 
results were presented as nmol/mg of protein.
Determination of Thioredoxin Reductase Activity
After 24 h of treatment with the tested compounds, thio-
redoxin reductase activity was measured by Thioredoxin 
streptomycin, and 2 mM l-glutamine. Cells w r  ain-
tained at 37 °C in a humidified incubator containing 5 % 
CO 2 atmosphere.
Cell Treatment Protocols
Equal PC12 cell numbers were seeded into 96-well 0.1 % 
polyethyleneimine-coated plate  at dens ty of 7.5 × 104/ml 
for MTT test, 2 × 105/ml for determination of apoptosis s 
well as the intracellular ROS levels and were grown o  
100 mm2  dishes to 90 % confluence for enzyme activity 
assays or on 60mm2  dishes to 90 % confluence for enzyme 
expression. After 24 h, the growth medium was changed to 
a low-serum medium (DMEM supplemented with 2 % FBS, 
50 U/ml penicillin/streptomycin, and 2 mM l-glutamine). 
Then the PC12 cells were treated with Selol or sodium sel-
enite, SNP (0–1 mM), and GPx inhibitor (sodium aurothio-
malate, SAu, 2 µM) for 24 h.
Determination of Cell Surviv l Using MTT Test
Cellular viability was evaluated by he reductio  of 
2-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl trazolium bro
mide (MTT) to formazan. After 24 h of treatm nt w th
the tested compounds, MTT (2.5 mg/ml) was added t all 
of the wells and was incubated at 37 °C for 2 h. Then he 
medium was removed, the formaz n crystals were dissolved 
in DMSO, and absorbance at 595 nm was measured. The 
results were presented as percent of control.
Determination of Apoptosis
The formation of apoptotic bodies was determined by micro-
scopic analysis of the cells stained with Hoechst 33258. 
Shortly, after 8 h of incubation in the presenc  of tested 
compounds, the cells were fixed, stained, and examined 
under a fluorescence microscope (Olympus BX51, Olym-
pus Corp., Tokyo, Japan) and photographed with a digit l
camera (Olympus DP70). Cells from ten random fields were 
counted under a 40× objective and the percentage of typical 
apoptotic nuclear morphology (nuclear s rinkage, conden-
sation) was calculated.
Determination of Se-Depende t Glutathione Peroxidase 
Activity
After 24 h of treatment with the tested compou ds, the glu-
tathione peroxidase activity was determin d by spectropho-
tometric assay based on the method of Paglia and Valentine 
[34], modified by Wendel [35]. Cells were homogen zed in 
cold buffer (50 mM Tris-HCl, pH = 7.5, 5 mM EDTA, 1 mM 
DTT) and centrifuged (10,000×g, 15 min, 4 °C), and th  
supernatant (20 µl) was used to analyz  enzyme activity and 
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manufacturer’s protocol (Applied Biosystems, Foster City, 
CA, USA). After 24 h of treatment with the tested com-
pounds, the mRNA levels for selected genes were analyzed 
using TaqMan Gene Expression Assays (Applied Biosys-
tems) according to the manufacturer’s instructions. Actb 
was used in all studies as the reference gene. Plates were 
analyzed on ABI PRISM 7500 apparatus (Applied Biosys-
tems). The relative levels of mRNA (Rq) were calculated 
using the ∆∆Ct method. The results were presented as per-
cent of control.
Protein Determination
Protein content was determined using Bradford protein 
assay according to the manufacturer’s protocol [37]. Stan-
dard curve for the assays was prepared with BSA. The 
absorbance of protein-bound dye [Coomassie Brilliant Blue 
G-250 (CBB G-250)] was measured at 595 nm.
Statistical Analysis
The results were expressed as mean values ± S.E.M. Dif-
ferences between means were analyzed using one-way 
ANOVA followed by the Newman–Keuls post hoc tests and 
p < 0.05 was considered statistically significant. The statisti-
cal analyzes were performed by using Graph Pad Prism ver-
sion 5.0 (Graph Pad Software, San Diego, CA).
Results
The study was started from the evaluation of the effects 
of Selol and SNP on PC12 cell viability. The MTT 
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide] tetrazolium reduction assay revealed that Selol con-
taining selenium at 5–400 μg/ml did not affect cell survival 
(Fig. 1a). Only at doses 500 µg/ml or higher, Se reduced 
cell viability (Fig. 1a). SNP (25–1000 μM, Fig. 1b) signifi-
cantly decreased cell viability in a dose-dependent manner. 
SNP at 500 µM was selected for further studies based on 
the cell viability score 50 (CVS50, concentration at which 
viability was ≤50 % of control) as indicated by the arrow in 
the figure. To select appropriate Se dose for cytoprotection 
against SNP-evoked toxicity, the dose-dependent effect of 
Selol (Se concentration, 5–50 μg/ml) on SNP-induced PC12 
cell death was evaluated (Fig. 1c). Selol containing Se at 
a dose 20 μg/ml completely inhibited SNP-evoked reduc-
tion of cell viability (Fig. 1c). Therefore, Selol containing 
20 μg Se/ml was chosen as the minimum effective dose to 
be used in the subsequent experiments as indicated by the 
arrow in the figure. The cytoprotective effect of Selol was 
compared with the influence of inorganic Se compound, 
sodium selenite (Na2SeO3). As shown in Fig. 1d, Na2SeO3 
Reductase Colorimetric Assay Kit (I em No. 10007892, 
Cayman Chemical, Ann Arbor, USA). Cells w e homog-
enized in cold buffer (50 mM potassium phosphate, pH 
7.4, containing 1 mM EDTA) and centrifuged (10,000×g, 
15 min, 4 °C). The supernatant (20 µl) w s used to an lyze 
enzyme activity and to determine protein content. The reac-
tion was initiated by adding 5,5-dithiobis-(2nitrobenzoic 
acid) (DTNB) solution and NADPH and the change in 
absorbance caused by the formation of 2-ni ro-5thiob nzoic 
acid (TNB) was measured once every 5 min at 405 m.
Measurement of TrxR activity by DTNB reduction in the 
absence and in the presence f aurothiomalate (20 µM), 
allows for correction of non-thioredoxin reductase-inde-
pendent DTNB reduction. Briefly, the reaction mixture 
contained 50 mM potassium phosphate (pH = 7.0), 50mM 
potassium chloride, 1 mM EDTA, and 0.2 mg/ml BSA. The 
results were presented as µm l/min/mg of prot in.
Determination of the Intracellular Levels of Reactive 
Oxygen Species
The intracellular ROS level was measured in adhe nt cells 
in 96-well black plates for 8 h as described previously [36]. 
The assay is based on the conversion of 2′,7′-dichlorodihy-
drofluorescein diacetate (H2DCF-DA) to 2′,7′-dichlorodi-
hydrofluorescin (H2DCF), which is then oxidized by free 
radicals to 2′,7′-dichlorofluorescein (DCF). Fluorescence 
was measured at 37 °C in Omega spectrofluorimeter (BMG 
Labtech GMBH, Ortenberg, Germany) at excitation and 
emission wavelengths of 488 and 525 nm, respectively. The 
results were presented as fluorescence intensity, percent of 
control.
Determination of Reactive Oxygen Species in Cell-Free 
System
The assay is based on the alkaline hydrolysis of 2′,7′-dichlo-
rodihydrofluorescein diacetate (H2DCF-DA) to 2′,7′dichlo-
rodihydrofluorescin (H2 DCF). Methanol, 2.5 mM 
2′,7′-dichlorodihydrofluorescein diacetate (H2 DCF-DA), and 
2 M KOH were mixed in a ratio of 1:1:0.5 and this m xture was 
kept in darkness at room temperature or 1 h. Then, HCl w s 
added to neutralize the mix ur (pH = 7). H2DCF is ox dized
by free radicals to 2′,7′-dichlorofluorescein (DCF). Fluores-
cence was measured for 70 min in Omega spectrofluorimeter 
(BMG Labtech GMBH, Ortenberg, Germany) at excitation 
and emission wavelengths of 488 and 525 nm, re pectively. 
The results were presented as fluorescence intensity.
Quantitative Real-Time PCR
Reverse transcription was perform d using H gh Capac-
ity cDNA Reverse Transcription Kit according to th  
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DNA-binding fluorochrome Hoechst 33258. Our result 
indicated that SNP induced apoptosis in PC12 cells with 
fragmentation of nuclei and formation of apoptotic bodies. 
had no protective effect agai st cell damage evoked by 
SNP. Quantitative analysis of apop osis was carried out 
via microscopic examination of cell nuclei stained with 
Fig. 1 The effect of Selol on SNP-evoked cell damage and death. a 
Concentration-dependent effect of Selol at selenium doses 5–600 µg/
ml on the viability of PC12 cells after 24 h  exposure. b Th  effec  
of SNP (0.025–1 mM) on PC12 cell viability. c The dose-dependent 
effect of Selol (5–50 μg/ml Se) on SNP-induced PC12 cell death. d 
Selol at the selected dose of 20 μg/ml Se prevented the reduction of 
cell viability evoked by 0.5 mM SNP while sodium selenite (Na2SeO3, 
20 μg Se/ml) had no influence. After 8 h of incubation, the level 
 apopto ic bod es in SNP- and Selol-/sodium elenite-treated cells. 
In the right panel, re rese tative fluorescent photomicrographs are 
shown; arrows indicate apoptotic bodies. Data expressed as percent-
age of apoptotic cells, n = 4–10. **p <0.01; ***p < 0.001 versus con-
trol (nontreated) cells; ##p < 0.01; ###p <0.001 versus SNP
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Selol treatment significantly decreased the percentage of 
apoptotic PC12 cells after SNP treatment (Fig. 1e), while 
Na2SeO3 was unable to protect against SNP-evoked apopto-
sis (Fig. 1e). In order to determine if Selol might influence 
the oxidative/nitrosative stress evoked by SNP, we evalu-
ated the effect of Selol on SNP-induced ROS accumulation. 
As shown in Fig. 2a, cells exposed to SNP exhibited higher 
oxidative stress, evaluated by DCF-DA fluorescence, when 
compared to the control group. Selol cotreatment decreased 
ROS level starting from the 4th hour of incubation (Fig. 2a). 
Similar results were obtained in cell-free system, Selol 
decreased fluorescence intensity induced by SNP (Fig. 2b). 
As glutathione is the first line of defense against oxida-
tive stress, we investigated the effect of Selol on the total 
intracellular level of glutathione as well as on its reduced 
(GSH) and oxidized (GSSG) forms. Although the total glu-
tathione level did not significantly change in SNP-treated 
group (Fig. 3a), a decrease in GSH and an increase in GSSG 
level were observed (Fig. 3 ). Selol treatment reversed 
glutathione oxidation induced by SNP, resulting in eleva-
tion of total (Fig.3a) and reduced glutathione as well as the 
decrease of GSSG (Fig. 3b), thus maintaining GSH/GSSG 
ratio (Fig. 3c). SNP also significantly disturbed the func-
tion of antioxidative enzymes. The activity and expression 
of Se-GPx were decreased by about 43 and 66 %, respec-
tively, an effect completely prevented by Selol treatment 
(Fig. 4a, b). GR was inhibited by 34 % by SNP (Fig. 4c) 
Fig. 3 The effect of Selol on SNP-mediated glutathione redox imbal-
ance. a Total glutathione and b ox dized (GSSG) as well as reduced 
(GSH) glutathione level after 24 h of incubation with Selol (20 μg/
ml Se) and SNP (0.5 mM). c GSH/GSSG rat o. n =4–6; *p< 0.05; 
**p < 0.01;***p< 0.001 versus control; #p< 0.05; ##p < 0.01 versus 
SNP
 
Fig. 2 The effect of Selol on time-dependent ROS generation induced 
by SNP. a PC12 cells treated with Selol (20 μg Se/ml) and SNP 
(0.5 mM) stained by DCFH-DA were subjected to fluorimetric analy-
sis for 8 h. b Fluorescence intensity was measured in the presence of 
Selol (20 μg Se/ml) and SNP (0.5 mM) for 70 min in cell-free system. 
Fluorescence intensity is expressed as percentage of control; n = 6–8; 
#p < 0.05; ##p < 0.01; ###p < 0.001 versus SNP
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Se-GPx inhibitor sodium aurothimalate (SAu). Both SAu, 
(2 μM) and SNP significantly reduced Se-GPx activity by 
about 60 % (Fig. 5a), but administration of SAu in com-
bination with SNP did not further reduce Se-GPx activity. 
Although Selol significantly prevented SNP-evoked Se-
GPx inhibition, it showed no effect in the presence of SAu 
or SNP + SAu (Fig. 5a). As indicated in Fig. 5b, both SNP 
and SAu reduced PC12 cell viability by about 40 % com-
pared to control. Selol was ineffective when these cells were 
subjected to SAu or SAu + SNP (Fig.5b).
with a concomitant increase in the mRNA level for this 
protein by 138 % (Fig. 4d). Selol treatment preve ted the 
inhibition of GR activity evoked by SNP (Fig. 4c) and sig-
nificantly reduced the upregulation of its mRNA (Fig. 4d). 
SNP also inhibited the Se-dependent thioredoxin reductase 
(TrxR) activity by about 61 % (Fig. 4e) and enhanced ts 
expression by 220 % (Fig. 4f); Selol significantly prevented 
these effects (Fig. 4e, f). Selol alone, however, moderately 
increased mRNA for Txnrd1 (by 53 %, Fig. 4f). To further 
investigate the cytoprotective action of Selol, we used the 
Fig. 4 The effect of Selol on SNP-evoked antioxidant enzyme 
changes. The activities and mRNA expression of antioxidant enzymes 
after 24 h of incubation of PC12 cells with Selol (20 μg Se/ml) and SNP 
(0.5 mM) were determined spectrophotometrically and by real-time 
quantitative RT-PCR as described in section “Materials and Methods”.
a, bSe-GPx; c, dGR and e, fTrxR. n = 4–10; *p < 0.05; ***p < 0.001 
versus control; #p < 0.05; ##p < 0.01; and ###p < 0.001 versus SNP
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retinal neuronal (RGC-5), and murine neuroblastoma 
N1E-115 cells [43–45]. In addition, this compound 
affected the expression of oxidative stress-related genes 
[46, 47]. SNP added to the cell culture could in part mimic 
the oxidative stress documented in the brains of patients 
with neurodegenerative disorders. We observed massive 
cell death with characteristic features of apoptosis in 
SNP-treated cells.
Potential therapeutic approaches for the treatment of 
neurodegenerative disorders include Se-based interven-
tions through incorporation of selenoamino acids into anti-
oxidative enzymes [48]. We provided experimental support 
for the hypothesis that Selol played a vital role in the anti-
oxidative response against SNP treatment, even if coad-
ministered at the time of cytotoxic insult. Sarker et al. have 
shown that 12 h of pretreatment with Ebselen [2-phenyl-1, 
2-benzisoselenazol-3 (2H)-one], a Se-containing heterocy-
clic organic compound, as well as with an inorganic com-
pound sodium selenite reduced PC12 cell death evoked by 
SNP [49]. However, in our study, sodium selenite added 
to the cell culture at the same time with stressor failed to 
protect from SNP-mediated cell death. It is possible that 
the ineffectiveness of inorganic selenium donor might be 
due to lower cell membrane permeability (leading to high 
toxicity). Moreover, the choice of organic Se compounds 
over their inorganic counterparts usually stems from their 
more efficient digestive tract absorption [50, 51]; it is 
possible that their action also differs significantly at the 
cellular level. To investigate if Selol could directly influ-
ence the levels of free radicals produced by SNP, we per-
formed DCF measurements of ROS in a cell-free system 
containing SNP and Selol. Our results show that Selol sig-
nificantly reduced free radical levels, thus suggesting that 
Selol’s action in the biological material might be also at 
least partially mediated by its direct influence on SNP. The 
cytotoxic action of SNP was accompanied by a collapse in 
the ratio of reduced to oxidized glutathione (GSH/GSSG) 
[42 , 52 ]. GSH is a cosubstrate of GPx that is responsible 
for the reduction of organic and inorganic hydroperoxides 
to water or alcohols with GSSG being a by-product. GSH 
can be restored either by GR in a NADPH-dependent reac-
tion or by the thioredoxin reductase/thioredoxin couple-
TrxR/Trx (rather slow) [53]. Changes in the GSH content 
mirror closely both oxidative stress and many kinds of 
pathologies linked to the dysregulation of the antioxidant 
network. We observed that the GSSG elevation indicated 
a shift toward more prooxidative cellular milieu and this 
might be due to direct reaction of GSH with ROS/RNS 
particularly hydroxyl radical (•OH), (NO) (after oxida-
tion to the NO+ form) and peroxynitrite (ONOO−). The 
reaction results the formation of thiyl radicals (GS•) that 
are, in turn, combining with other thiyl radicals to form 
glutathione disulfide [54]. We showed that the protective 
Discussion
Oxidative stress is increasingly recogn zed as an impor-
tant mechanism of neurodegen rative disorders and thus 
has become an attractive therapeutic target. PC12 c lls 
serve as a common model for the investigati n f neu-
rotoxic effects of stress [38 ] as well as neuroprotection 
induced by candidate drugs [39]. Selenium can be either 
pro- or antioxidant in various circumstances [29 , 40] and 
may thus be either neuroprotective or cytotoxic [41]. 
In the present study we de onst ate that Selol potently 
inhibits SNP-induced dopaminergic PC12 cel  death. SNP 
is among the most widely studied NO donors. Moreover,
this NO-releasing compound could exert toxic ffects as 
a result of its breakdown to another toxic species, includ-
ing CN−, Fe2+, H2O 2 , and [Fe(CN6)]
4− [13]. Treatmen  
with SNP increased total ROS and ONOO− generation 
in human dopaminergic neuroblast ma cel s (SH-SY5Y) 
[42]. SNP-evoked toxicity mediated by ROS generat on
was also demonstrated in rat adrenal pheochromocytoma, 
Fig. 5 Sodium aurothiomalate (SAu) abolished the protective effect of 
Selol against SNP toxicity. PC12 cells were exposed to Selol at 20 μg/
ml Se, SAu (2 μM), and SNP (0.5 mM) for 24 h, and then the enzyme 
activity and cell viability were analyz d using spectrophotometry. a 
The effect of SAu on GPx activity. b MTT test of cell survival. n = 4–8;
***p < 0.001 versus control; ###p< 0.001 versus SNP
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mRNA abundance control (probably via degradation) and 
a translational change (the meaning of UGA is modified 
from ‘stop’ to ‘selenocysteine’). Under standard condi-
tions, the UGA stop codon is bypassed and selenocysteine 
is incorporated, but at conditions of selenium deficiency, 
this UGA sequence seems to revert to its standard meaning 
as a termination codon. This additionally leads to a reduc-
tion in GPx1 mRNA, possibly through a mechanism that 
ensures the removal of aberrant mRNAs that prematurely 
terminate transcription [63–67]. Together with our obser-
vations, this might suggest that under SNP conditions, the 
supply of selenium becomes a limiting factor, either via Se 
incorporation, or through Selol’s antioxidative effects (ROS 
scavenging, induction of gene activities). Therefore, Selol 
treatment increased the transcription levels of the GPx1 
under condition of SNP that may facilitate the protein syn-
thesis, and may further elevate its activity. Selol at the same 
time decreased the level of Gsr and Txnrd1in SNP-treated 
cells. To further characterize the activation of antioxidant 
enzymes by Selol under condition of SNP, we used GPx 
inhibitor (sodium aurothiomalate; SAu). Either SAu or SNP 
significantly reduced Se-GPx activity when administered 
alone, but SAu in combination with SNP did not further 
reduce Se-GPx activity. Selol prevented Se-GPx inhibition 
caused by SNP, but not by SAu or SNP in combination with 
SAu. This suggests that the effect of Selol might be linked to 
the antagonistic action against SNP/SNP-produced ROS, in 
accordance with our in vitro DCF data. However, blockage 
of Se access to the enzyme’s catalytic center by SAu could 
not be ruled out. Our results showed that treatment with 
SAu prevented the protective effect of Selol against SNP-
induced apoptosis, again suggesting the involvement of Se-
GPx in the protective effect of Selol against SNP-evoked 
toxicity. As SAu is also able to inhibit the activity of TrxR 
[68], this enzyme’s role as a target in Selol-mediated protec-
tion cannot be excluded, although its changes in response to 
Selol treatment are less evident.
In summary, we propose a model whereby Selol mod-
ulates the impact of SNP on GPx and other antioxidant 
enzymes and prevents SNP-induced cell death. This suc-
cessful in vitro application in a model of ROS-/RNS-medi-
ated cytotoxicity suggests Selol as a promising compound 
in therapy of diseases related to oxidative/nitrosative dam-
age and dopaminergic cells death. This potentially attractive 
mechanism deserves further in vivo clarification including 
in-depth analysis of Selol’s impact on other aspects of neu-
ronal death mechanisms.
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mechanism of Selol against SNP cytotoxicity included 
significant inhibition of ROS production along with the 
restoration of GSH homeostasis, and the expression/ac iv-
ity of antioxidative enzymes. Similarly, Aykin-Burns et 
al. showed that selenocyst e (SeCys) also ameliorated 
lead-induced imbalance of the GSH/GSSG ratio [55]. 
In addition, pretreatment with S Met for 16 h has been 
shown to protect primary rat hippocam al neurons against 
the toxicity of ROS generated by iron/hydrogen perox-
ide (Fe2+/H2O 2 ) or amyloid β. The effect was mediated 
by increased GPx protein and activity [56]. In our s udy, 
the administration of SNP in PC12 cells led to significant 
depletion of antioxidant activities, which is in accordance 
with the report of Pandareesh and Anand [52 ]. However, it 
could be debated whether the reduc io  in Se-GPx activ-
ity is due to some regulatory events, or might s em from 
a decline in its expression wh le GR and TrxR appear to 
undergo inhibition. Selol significantly ameliorated the 
SNP-induced inhibition of GSH-dependent antioxidative 
enzymes (GPx, GR) and TrxR. Similar effect was proved 
by Song et al.; they showed t at mycotoxin-mediated inhi-
bition of GPx and GR was rel eved by supplementat on 
of organic or inorganic Se [57]. Moreover, the organic 
Se–Met (and the inorganic compounds to a lesser degree) 
increased the expression of mRNAs coding GPx1 and 
GPx4 [57]. The expression of several crucial antioxidative 
enzymes including Txnrd1, GPx1 and sr is under the 
control of Nrf2 (nuclear factor-erythroid 2-related factor 
2). Nrf2 promotes the regulation of the intrac llular redox 
environment and cytoprotection via binding to the pro-
moter sequences termed antioxidant responsive lement 
(ARE) and up-regulating the transcription of ARE-con-
taining antioxidant genes [58 –60]. Treatment of cells with 
Selol followed by SNP exposure resulted in the increase of 
target genes expression, thus it  likely that Nrf2 mediates 
the observed effects. It correspo ds with a report where 
selenite induced protective changes in mitochondrial bio-
genesis by increasing the level of N f1 and nuclear accu-
mulation of Nrf2 [61].
In our study, SNP significantly decreased GPx1 mRNA 
expression and in parallel increased Gsr nd Txnrd1 
mRNAs. We interpreted that the epleti n of enzymatic 
activity of GR and TrxR after SNP xposure led to com-
pensatory upregulation of th ir express on to cope with e
stress. However, poor correlation b twee  GPx a tivity and 
its mRNA expression in the presence of SNP may indicate 
that translational or posttranslational mechanism(s) might 
be involved in its regulation. Such post-translational modifi-
cations might involve not only enzymatic reactions, but also 
direct free radical-induced damage, such as S-nitrosylation. 
Such modulation occurs e.g i the case of the thioredox n—
TrxR system [62]. Interestingly, GPx1 mRNA may be the 
target of two stop codon-mediated modulation mechanisms: 
1 3
Neurochem Res (2016) 41:3215–3226 3223
the production of different reactive molecules. Eur J pharmacol 
400(1):19–33
14. Kim HY, Gladyshev VN (2007) Methionine sulfoxide reductases: 
selenoprotein forms and roles in antioxidant protein repair in 
mammals. Biochem J 407(3):321–329. doi:10.104 /bj20070929
15. Papp LV, Lu J, Holmgren A, Khanna KK (2007) From selenium to 
selenoproteins: synthesis, identity, and their role in human health. 
Antioxid Redox Signal 9(7):775–806. doi:10.1089/ars.2007.1528
16. Huang Z, Rose AH, Hoffmann PR (2012) The role of selenium 
in inflammation and immunity: from molecular mechanisms to 
therapeutic opportunities. Antioxid Redox Signal 16(7):705–743. 
doi:10.1089/ars.2011.4145
17. Akbaraly TN, Hininger-Favier I, Carriere I, Arnaud J, Gourlet 
V, Roussel AM, Berr C (2007) Plasma selenium over time and 
cognitive decline in the elderly. Epidemiology 18(1):52–58. 
doi:10.1097/01.ede.0000248202.83695.4e
18. Cutts DA, Maguire RP, Stedman JD, Leenders KL, Spyrou NM 
(1999) A comparative study in Alzheimer’s and normal brains of 
trace element distribution using PIXE and INA analyses and glu-
cose metabolism by positron emission tomography. Biol Trace 
Elem Res 71–72:541–549
19. Cardoso BR, Ong TP, Jacob-Filho W, Jaluul O, Freitas MI, Coz-
zolino SM (2010) Nutritional status of selenium in Alzheim-
er’s disease patients. Br J Nutr 103(6):803–806. doi:10.1017/
s0007114509992832
20. Shahar A, Patel KV, Semba RD, Bandinelli S, Shahar DR, Fer-
rucci L, Guralnik JM (2010) Plasma selenium is positively related 
to performance in neurological tasks assessing coordination 
and motor speed. Mov Disord 25(12):1909–1915. doi:10.1002/
mds.23218
21. Vural H, Demirin H, Kara Y, Eren I, Delibas N (2010) Alterations 
of plasma magnesium, copper, zinc, iron and selenium concen-
trations and some related erythrocyte antioxidant enzyme activi-
ties in patients with Alzheimer’s disease. J Trace Elem Med Biol 
24(3):169–173. doi:10.1016/j.jtemb.2010.02.002
22. Loef M, Schrauzer GN, Walach H (2011) Selenium and Alzheim-
er’s disease: a systematic review. J Alzheimers Dis 26(1):81–104. 
doi:10.3233/jad-2011-110414
23. Mehrpour M, Kyani A, Tafazzoli M, Fathi F, Joghataie MT 
(2013) A metabonomics investigation of multiple sclerosis by 
nuclear magnetic resonance. Magn Reson Chem 51(2):102–109. 
doi:10.1002/mrc.3915
24. Lu Z, Marks E, Chen J, Moline J, Barrows L, Raisbeck M, Voli-
takis I, Cherny RA, Chopra V, Bush AI, Hersch S, Fox JH (2014) 
Altered selenium status in Huntington’s disease: neuroprotection 
by selenite in the N171-82Q mouse model. Neurobiol Dis 71:34–
42. doi:10.1016/j.nbd.2014.06.022
25. Ramoutar RR, Brumaghim JL (2010) Antioxidant and antican-
cer properties and mechanisms of inorganic selenium, oxo-sulfur, 
and oxo-selenium compounds. Cell Biochem Biophys 58(1):1–
23. doi:10.1007/s12013-010-9088-x
26. Letavayova L, Vlasakova D, Spallholz JE, Brozmanova J, Cho-
vanec M (2008) Toxicity and mutagenicity of selenium com-
pounds in Saccharomyces cerevisiae. Mutat Res 638(1–2):1–10. 
doi:10.1016/j.mrfmmm.2007.08.009
27. Rayman MP (2008) Food-chain selenium and human health: 
emphasis on intake. Br J Nutr 100(2):254–268. doi:10.1017/
s0007114508939830
28. Letavayova L, Vlckova V, Brozmanova J (2006) Selenium: from 
cancer prevention to DNA damage. Toxicology 227(1–2):1–14. 
doi:10.1016/j.tox.2006.07.017
29. Weekley CM, Harris HH (2013) Which form is that? The impor-
tance of selenium speciation and metabolism in the prevention 
and treatment of disease. Chem Soc Rev 42(23):8870–8894. 
doi:10.1039/c3cs60272a
Compliance with Ethical Standards
Conflict of Interest The authors declare that they have no conflict 
of interest.
Ethical Approval This article does not contain any studies wit  
human participants or animals performed by any of the authors. For 
this type of study formal consent is not required.
Open Access Thi  article is distributed under the terms of the 
Creative Commons Attribution 4.0 International License (http://cr-
ativecommons.org/licenses/by/4.0/), which permits unrestricted use, 
distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and i dicate if changes were 
made.
References
 1. Belanger M, Allaman I, Magistretti PJ (2011) Brain energy 
metabolism: focus on astrocyte-neuron metabolic cooperation. 
Cell Metab 14(6):724–738. doi:10.1016/j.cmet.2011.08.016
 2. Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxida-
tive stress in neurodegenerative diseases. Nature 443(7113):787–
795. doi:10.1038/nature05292
 3. Gandhi S, Abramov AY (2012) Mechanism of oxidative stress 
in neurodegeneration. Oxid Med Cell L ngev 2012:428010. 
doi:10.1155/2012/428010
 4. Bradley SA, Steinert JR (2016) Nitric Oxid -Medi ted Posttrans-
lational Modifications: Impacts at the Synapse. Oxid Med Cell 
Longev 2016:5681036. doi:10 1155/2016/5681036
 5. Chiueh CC, Andoh T, Lai AR, Lai E, Krishna G (2000) Neuropro-
tective strategies in Parkinson’s disease: protection against pro-
gressive nigral damage induced by free radicals. Neurotox Res 
2(2–3):293–310
 6. Halliwell B (2001) Role of free ra icals in the neurodegenera-
tive diseases: therapeutic implications for antioxid nt treatment. 
Drugs Aging 18(9):685–716
 7. Almeida S, Alves MG, Sousa M, Oliveira PF, Silva BM (2016) Are 
polyphenols strong dietary agents against neurotoxicity and neu-
rodegeneration? Neurotox Res. doi:10.1007/s12640-015-9590-4
 8. Gilgun-Sherki Y, Melamed E, Offen D (2004) The role of oxi-
dative stress in the pathogenesis of multiple sclero is: the need 
for effective antioxidant therapy. J Neurol 251(3):261–268. 
doi:10.1007/s00415-004-0348-9
 9. Henchcliffe C, Beal MF (2008) Mitochondrial biology and oxi-
dative stress in Parkinson disease athogen is. Nat Cli  Pract 
Neurol 4(11):600–609. doi:10.1038/ncpneuro0924
10. Pratico D (2008) Evidence of oxidative stress in Alzheimer’s dis-
ease brain and antioxidant therapy: lights and shad ws. Ann N Y 
Acad Sci 1147:70–78. doi:10.1196/annals.1427.010
11. Puertas MC, Martinez-Martos JM, Cobo MP, Carrera MP, 
Mayas MD, Ramirez-Exposito MJ (2012) Plasma oxidative 
stress parameters in men and women with early stage Alzheim r 
type dementia. Exp Gerontol 47(8):625–630. doi:10.1016/j.
exger.2012.05.019
12. D’Amico E, Factor-Litvak P, Santella RM, Mitsumoto H (2013) 
Clinical perspective on oxidative stress in sporadic amyotrophic 
lateral sclerosis. Free Radic Biol Med 65:509–527. doi:10.1016/j.
freeradbiomed.2013.06.029
13. Terwel D, Nieland LJ, Schutte B, Reutelingsperger CP, Rama k-
ers FC, Steinbusch HW (2000) S-nitroso-N-acetylp icillamine 
and nitroprusside induce apoptos s in a neuronal cell line by 
1 3
Neurochem Res (2016) 41:3215–32263224
and hepatic catalase activity in mice. J Drug Deliv 2015:790480. 
doi:10.1155/2015/790480
48. Tapiero H, Townsend DM, Tew KD (2003) The antioxidant 
role of selenium and seleno-compounds. Biomed Pharmacother 
57(3–4):134–144
49. Sarker KP, Biswas KK, Rosales JL, Yamaji K, Hashiguchi T, Lee 
KY, Maruyama I (2003) Ebselen inhibits NO-induced apoptosis 
of differentiated PC12 cells via inhibition of ASK1-p38 MAPK-
p53 and JNK signaling and activation of p44/42 MAPK and Bcl-
2. J Neurochem 87(6):1345–1353
50. Lassen KO, Horder M (1994) Selenium status and the effect of 
organic and inorganic selenium supplementation in a group of 
elderly people in Denmark. Scand J Clin Lab Invest 54(8):585–590
51. Musik I, Koziol-Montewka M, Tos-Luty S, Donica H, Pasternak 
K, Wawrzycki S (2002) Comparison of selenium distribution in 
mice organs after the supplementation with inorganic and organic 
selenium compound selenosemicarbazide. Ann Univ Mariae 
Curie Sklodowska Med 57(1):15–22
52. Pandareesh MD, Anand T (2014) Neuroprotective and anti-
apoptotic propensity of Bacopa monniera extract against sodium 
nitroprusside induced activation of iNOS, heat shock proteins and 
apoptotic markers in PC12 cells. Neurochem Res 39(5):800–814. 
doi:10.1007/s11064-014-1273-7
53. Deponte M (2013) Glutathione catalysis and the reaction mecha-
nisms of glutathione-dependent enzymes. Biochim Biophys Acta 
1830(5):3217–3266. doi:10.1016/j.bbagen.2012.09.018
54. Lushchak VI (2012) Glutathione homeostasis and functions: 
potential targets for medical interventions. J Amino Acids 
2012:736837. doi:10.1155/2012/736837
55. Aykin-Burns N, Ercal N (2006) Effects of selenocystine on lead-
exposed Chinese hamster ovary (CHO) and PC-12 cells. Toxicol 
Appl Pharmacol 214(2):136–143. doi:10.1016/j.taap.2005.12.002
56. Xiong S, Markesbery WR, Shao C, Lovell MA (2007) Seleno-
l-methionine protects against beta-amyloid and iron/hydro-
gen peroxide-mediated neuron death. Antioxid Redox Signal 
9(4):457–467. doi:10.1089/ars.2006.1363
57. Song E, Su C, Fu J, Xia X, Yang S, Xiao C, Lu B, Chen H, Sun 
Z, Wu S, Song Y (2014) Selenium supplementation shows pro-
tective effects against patulin-induced brain damage in mice via 
increases in GSH-related enzyme activity and expression. Life 
Sci 109(1):37–43. doi:10 1016/j.lfs.2014.05.022
58. Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Ban-
nai S, Yamamoto M (2000) Transcription factor Nrf2 coordi-
nately regulates a group of oxidative stress-inducible genes in 
macrophages. J Biol Chem 275(21):16023–16029
59. Tanito M, Agbaga MP, Anderson RE (2007) Upregulation of 
thioredoxin system via Nrf2-antioxidant responsive element 
pathway in adaptive-retinal neuroprotection in vivo and in 
vitro. Free Radic Biol Med 42(12):1838–1850. doi:10.1016/j.
freeradbiomed.2007.03.018
60. Podder B, Kim YS, Song HY (2013) Cytoprotective effect of 
bioactive sea buckthorn extract on paraquat-exposed A549 cells 
via induction of Nrf2 and its downstream genes. Mol Med Rep 
8(6):1852–1860. doi:10.3892/mmr.2013.1736
61. Wojewoda M, Duszynski J, Szczepanowska J (2011) NARP muta-
tion and mtDNA depletion trigger mitochondrial biogenesis which 
can be modulated by selenite supplementation. Int J Biochem 
Cell Biol 43(8):1178–1186. doi:10. 016/j.biocel.2011.04.011
62. Benhar M (2015) Nitric oxide and the thioredoxin system: a 
complex interplay in redox regulation. Biochim Biophys Acta 
1850(12):2476–2484. doi:10.1016/j.bbagen.2015.09.010
63. Moriarty PM, Reddy CC, Maquat LE (1998) Selenium deficiency 
reduces the abundance of mRNA for Se-dependent glutathione 
peroxidase 1 by a UGA-dependent mechanism likely to be non-
sense codon-mediated decay of cytoplasmic mRNA. Mol Cell 
Biol 18(5):2932–2939
30. Suchocki P, Jakoniuk D, Fitak BA (2003) Specific spectropho-
tometric method with trifluoroacetic acid for the determination 
of selenium(IV) in selenitetriglycerides. J Pharm Biomed Anal 
32(4–5):1029–1036
31. Jastrzebski Z, Czyzewska-Szafran H, Fijatek Z, Suchocki P, Fitak 
BA (1995) Toxicity studies of a new selenium compound, Selol, 
in rats. Drugs Exp Clin Res 21(6):217–220
32. Rahden-Staron I, Suchocki P, Czeczot H (2010) Evaluation of 
mutagenic activity of the organo-selenium compound Selol by 
use of the Salmonella typhimurium m tagenicity assay. Mutat 
Res 699(1–2):44–46. doi:10.1016/j.mrgentox.2010.04.018
33. Jastrzebski Z, Czyzewska-Szafran H, Remiszewska M, Fijalek 
Z, Fitak BA, Suchocki P (1997) Pharmacokinetics of selol,  
new agent containing selenium, in rats. Drugs Expl Clinic Res 
23(1):7–11
34. Paglia DE, Valentine WN (1967) Studies on the quantitative and 
qualitative characterization of erythro yte glutathione peroxi-
dase. J Lab Clin Med 70(1):158–169
35. Wendel A (1981) Glutathione peroxidase. Methods Enzymol 
77:325–333
36. Adamczyk A, Kazmierczak A, Strosznajder JB (2006) Alpha-
synuclein and its neurotoxic fragment nhibit dopamine uptake 
into rat striatal synaptosomes. Relationship to nitric oxide. Neu-
rochem Int 49(4):407–412. doi:10.1016/j.neuint.2006 01.025
37. Bradford MM (1976) A rapid and sensitive method for the quan-
titation of microgram quantities of protein utilizing the principle 
of protein–dye binding. Anal Biochem 72:248–254
38. Piga R, Saito Y, Yoshida Y, Niki E (2007) Cytotoxic effects 
of various stressors on PC12 cells: involvement of oxidative 
stress and effect of antioxidants. Neurotoxicology 28(1):67–75. 
doi:10.1016/j.neuro.2006.07.006
39. Oliveira MT, Rego AC, Morgadinho MT, Macedo TR, Oliveira 
CR (2002) Toxic effects of opioid and stimulant drugs on undif-
ferentiated PC12 cells. Ann N Y Acad Sci 965:487–496
40. Lee KH, Jeong D (2012) Bimodal actions of s len um essen ial 
for antioxidant and toxic pro-oxidant activities: the selenium 
paradox (Review). Mol Med Rep 5(2):299–304. doi:10.3892/
mmr.2011.651
41. de Souza LR, Muehlmann LA, Matos LC, Simon-Vazqu z R, 
Lacava ZG, De-Paula AM, Mosiniewicz-Szablewska E, Suchocki 
P, Morais PC, Gonzalez-Fernandez A, Bao SN, Azevedo RB (2015) 
Antitumor activity and systemic effects of PVM/MA-shelled selol 
nanocapsules in lung adenocarcinoma-be ring mice. Nanotech-
nology 26(50):505101. doi:10.1088/0957-4484/26/50/505101
42. Chun HS, Low WC (2012) Ursodeoxycholic acid suppresses
mitochondria-dependent programmed cell death induced by 
sodium nitroprusside in SH-SY5Y cells. Toxicology 292(2–
3):105–112. doi:10.1016/j.tox.2011.11.020
43. Yamada M, Momose K, Richelson E, Yamada M (1996) Sodium 
nitroprusside-induced apoptotic c llular d ath via production of 
hydrogen peroxide in murine neuroblastoma N1E-115 cells. J 
Pharmacol Toxicol Methods 35(1):11–17
44. Nakamura Y, Yasuda M, Fujimori H, Kiyono M, Pan-Hou H 
(1997) Cytotoxic effect of sodium nitroprusside on PC12 cells. 
Chemosphere 34(2):317–324
45. Wang R, Yang J, Liao S, Xiao G, Luo J, Zhang L, Little PJ, Chen 
H, Zheng W (2014) Stereoselective reduction of 1-O-isopropy-
loxygenipin enhances its neuroprotective activity n n uronal 
cells from apoptosis induced by sodium nitroprusside. ChemMe-
Chem 9(7):1397–1401. doi:10 1002/cmdc.201400051
46. Ma L, Johnson P (1999) Antihypertensive drug therapy and 
antioxidant enzyme mRNA levels in spontaneously hyp rt n-
sive (SHR) rats. Comp Biochem Physiol B Bioc m Mol Biol 
122(1):119–126
47. Sani M, Sebai H, Refinetti R, Mondal M (2015) Dosing-time 
dependent effects of sodium nitroprusside on cerebral, renal, 
1 3
Neurochem Res (2016) 41:3215–3226 3225
67. Tsuji PA, Carlson BA, Anderson CB, Seifried HE, Hatfield 
DL, Howard MT (2015) Dietary selenium levels affect seleno-
protein expression and support the interferon-gamma and IL-6 
immune response pathways in mice. Nutrients 7(8):6529–6549. 
doi:10.3390/nu7085297
68. Rigobello MP, Scutari G, Folda A, Bindoli A (2004) Mitochon-
drial thioredoxin reductase inhibition by gold(I) compounds and 
concurrent stimulation of permeability transition and release of 
cytochrome c. Biochem Pharmacol 67(4):689–696
64. Lubos E, Loscalzo J, Handy DE (2011) Glutathione peroxidase-1 
in health and disease: from molecul  mechanisms to thera-
peutic opportunities. Antioxid Redox Signal 15(7):1957–1997.
doi:10.1089/ars.2010.3586
65. Sunde RA, Raines AM (2011) Selenium regulation of the seleno-
protein and nonselenoprotein transcript mes in rodents. Adv Nutr 
2(2):138–150. doi:10.3945/an.110.000240
66. Howard MT, Carlson BA, Anderson CB, Hatfield DL (2013) 
Translational redefinition of UGA codons is regulated by selenium 
availability. J Biol Chem 288(27):19401–19413. doi:10.1074/jbc.
M113.481051
1 3
Neurochem Res (2016) 41:3215–32263226
